Pancreatic cancer cell samples (DIA)
Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
SUBMITTER: 
Farnusch Kaschani
LAB HEAD: Farnusch Kaschani
PROVIDER: PXD063917 | Pride | 2026-04-21
REPOSITORIES: Pride
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| ACE_0882_NK01.raw | Raw | |||
| ACE_0882_NK02.raw | Raw | |||
| ACE_0882_NK03.raw | Raw | |||
| ACE_0882_NK04.raw | Raw | |||
| ACE_0882_NK05.raw | Raw |
Items per page: 5 1 - 5 of 48 |
Similar Datasets
Project description:Whole proteome measurement to determine selectivity profile for compound NK266 in melanoma as well as determining downstream signalling effects of DUB inhibition and degradation.
2026-04-21 | PXD063920 | Pride
Project description:Whole Proteome measurement of pancreatic cancer cells (Panc89) or melanoma cells (MaMel47) treated with USP7 inhibitors and degrader to compare phenotypes induced by inhibition compared to degradation. We synthesized and characterized potent USP7-targeting degrader molecules (PROTACs) and compared USP7 degradation to inhibition
2026-04-21 | PXD070431 | Pride
Project description:Whole proteome measurement to determine selectivitiy profile for compound NK250 in pancreatic cancer as well as determining downstream signaling effects of DUB inhibition and degradation.
2026-04-21 | PXD063913 | Pride
Project description:Competitive target ID for inhibitor NK192. To this end the inhibitor was decorated with biotin and used in a pull-down experiment to pull out the desired on-target (USP7) and possible off-targets. The samples were analysed by LC-MS.
2026-04-21 | PXD063889 | Pride
Project description:In this study, we investigate the intraoperative protein adsorption on the synthetic bone substitutes β-TCP (tricalcium phosphate) and PCL (polycaprolactone) using two different adsorption techniques.
2025-10-06 | PXD066010 | Pride
Project description:The ability to conduct high-quality proteomic experiments in high throughput has opened new avenues in clinical research, drug discovery, and systems biology. Next to an increase in quantitative precision, recent developments in high-throughput proteomics have also gained proteomic depth, to the extent that earlier gaps between classic and high-throughput experiments have significantly narrowed. Here we introduce and benchmark Zeno SWATH, a data-independent acquisition technique that employs a linear ion trap pulsing (Zeno trap pulsing) in order to increase proteomic depth and dynamic range in proteomic experiments. Combined with the high acquisition speed, these gains in sensitivity are particularly attractive for conducting high-throughput proteomics experiments with high chromatographic flow rates and fast gradients. We demonstrate that when combined with either micro-flow- or analytical-flow-rate chromatography, Zeno SWATH increases protein identification in complex samples 5- to 10-fold when compared to current SWATH acquisition methods on the same instrument. Using 20-min micro-flow chromatography, Zeno SWATH identified > 6,000 proteins from a 62.5 ng load of human cell lysate with more than 5,000 proteins consistently quantified in triplicate injections with a median CV of 6%. Using 5-min analytical-flow-rate chromatography (800 µl/min), Zeno SWATH identified 4,907 proteins from a triplicate injection of 2 µg of a human cell lysate; or more than 3,000 proteins from 250 ng tryptic digest. Zeno SWATH hence facilitates precise proteomic experiments with small sample amounts using a fast and robust high flow-rate chromatographic method, broadening the application space that requires precise proteomic experiments on a large scale.
2022-12-01 | PXD036786 | Pride
Project description:Rheumatoid arthritis (RA) is a systemic autoimmune and inflammatory disease. Plasma biomarkers are critical for understanding disease mechanisms, treatment effects, and diagnosis. Mass spectrometry-based proteomics is a powerful tool for unbiased biomarker discovery. However, plasma proteomics is significantly hampered by signal interference from high-abundance proteins, low overall protein coverage, and high levels of missing data from data-dependent acquisition (DDA). To achieve quantitative proteomic analysis for plasma samples with a balance of throughput, performance, and cost, we developed a workflow incorporating plate-based high abundance protein depletion and sample preparation, comprehensive peptide spectral library building, and data-independent acquisition (DIA) SWATH mass spectrometry-based methodology. In this study, we analyzed plasma samples from both RA patients and healthy donors. The results showed that the new workflow performance exceeded that of the current state-of-the-art depletion-based plasma proteomic platforms in terms of both data quality and proteome coverage. Proteins from biological processes related to the activation of systemic inflammation, suppression of platelet function, and loss of muscle mass were enriched and differentially expressed in RA. Some plasma proteins, particularly acute phase reactant proteins, showed great power to distinguish between RA patients and healthy donors. Moreover, protein isoforms in the plasma were also analyzed, providing even deeper proteome coverage. This workflow can serve as a basis for further application in discovering plasma biomarkers of other diseases.
2023-10-25 | PXD045171 | Pride
Project description:Background: Aggressiveness guides treatment in IDH-mutant gliomas. Objective grading of oligodendrogliomas is therefore urgently needed. Material and Methods: 211 primary and recurrent resections from 111 oligodendroglioma patients were collected, complemented with 91 samples for validation. Samples were subjected to Ki-67 staining, proteomics and DNA-methylation profiling. Data were analyzed using various multivariate differential models and algorithms. Results & conclusion: We developed CGCψ, a continuous grading coefficient independent of tumor typing, and demonstrate its prognostic value in oligodendrogliomas. Its prognostic value outperformed WHO grade at tumor recurrence. CGCψ is linked to large scale DNA de-methylation, but increased DNA methylation of polycomb transcription factors, aging, Ki-67, and losses on chr4 and chr9p. DNA de-methylation at tumor recurrence/higher grade is sequence context specific and associated with TET recognition sites. Both oligodendrogliomas and astrocytomas progress along this shared epi-genetic axis. Oligosarcomas are characterized by a high CGCψ and low tumor purity.
2026-01-19 | PXD070222 | Pride
Project description:Brown adipose tissue (BAT) is involved in dissipating energy as heat (non-shivering thermogenesis), not only under cold exposure but also in the dissipation of excess ingested energy. Therefore, harnessing energy utilisation by BAT is a potential avenue to combat weight gain and its comorbidities. Dietary macronutrient composition can directly influence BAT size and has recently been shown to influence BAT size of daughters through non-genetic effects in the patriline of C57BL/6J mice. However, the effects of dietary macronutrient composition and any non-genetic paternal effects on BAT function have yet to be characterised. Using the Geometric Framework for Nutrition, we investigated the effects of dietary protein, carbohydrate, and fat composition on the BAT proteome in male mice (F0) and intergenerational effects in their offspring (F1). In F0 males, >50% of the proteome was affected by dietary macronutrient composition, with distinct clusters of proteins that responded to diet in similar ways. We identified two clusters with inverse expression patterns that correlated with BAT weight. Notably, Ucp1 was reduced on low fat diet compositions that promoted increased BAT mass, while on those same diets there were increased levels of proteins involved in protein turnover. These diets also led to a reduction in proteins involved in purine biosynthesis (often Ucp1 inhibitors) and increased Hsl, which facilitates free fatty acid release, critical for Ucp1 activation. We did not find any effects of paternal diet on the BAT proteome in sons, but paternal protein intake negatively affected Basigin expression in daughters; a protein that regulates Ucp1 transcription. Our study is the first characterisation of BAT protein abundance across a broad range of dietary macronutrient compositions and across two generations, with implications for our understanding of non-shivering thermogenesis and metabolism.
2025-06-27 | PXD060130 | Pride
Project description:The rapid rise of Monkeypox (MPX) cases outside previously endemic areas prompt for a better understanding of the disease. We studied the plasma proteome of a group of MPX patients with a similar infection history and clinical manifestation typical for the current outbreak. We report that MPX is associated with a strong plasma proteomic response among nutritional and acute phase response proteins. Moreover, we report a correlation between plasma proteins and disease severity. Contrasting the MPX host response with that of COVID-19, we find a range of similarities, but also important differences. For instance, CFHR1 is induced in COVID-19, but suppressed in MPX, reflecting the different role of the complement system in the two infectious diseases. The partial overlap in response proteins, however, allowed us to explore repurposing of a COVID-19 biomarker panel assay, which resulted in successful patient classification. Hence, our results provide a first proteomic characterization of the MPX human host response, and we reveal a thus far untapped potential for accelerating the response to disease outbreaks through the repurposing of biomarker assays.
2022-09-22 | PXD036074 | Pride